Proteomic Analysis in Multiple Myeloma Research

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

ČUMOVÁ Jana POTÁČOVÁ Anna ZDRÁHAL Zbyněk HÁJEK Roman

Year of publication 2011
Type Article in Periodical
Magazine / Source Molecular biotechnology
MU Faculty or unit

Faculty of Medicine

Citation
Doi http://dx.doi.org/10.1007/s12033-010-9326-x
Field Oncology and hematology
Keywords proteomics; multiple myeloma; mass spectrometry; biomarker
Description Multiple myeloma (MM) is an incurable plasma cell (PC) malignancy characterized by the accumulation of monoclonal PCs in the bone marrow. For deeper understanding of the molecular mechanisms involved in the development of this disease, the influence of microenvironment, or the prediction of response of tumor PCs to anti-MM treatment, it is possible to use modern technologies for genomic and proteomic analyses. Due to progress in instrumentation, one of the main tools of proteomic analysis is mass spectrometry in combination with chosen separation techniques. This review will provide a short survey of the most commonly used proteomic techniques and show examples of their applications in MM proteome studies.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.